India is quite good at pharmaceuticals -- their generics basically serve the rest of the world that are priced out of US-made products IIRC.

Ex. their generic version of Paxlovid:

https://www.reuters.com/business/healthcare-pharmaceuticals/...

Basically, with the expiring patents coming up on a bunch of these drugs:

https://www.biospace.com/article/9-drugs-losing-patents-or-e...

We're going to be in interesting waters soon.